Zymergen researches, develops and manufactures microbes. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues by first responders, such as firemen, paramedics, flight crews and others either inside the body or on the skin to close a wound or to protect against infection. The Company uses a technology platform to optimize strains in that improves economics, improves the existing production strains within existing manufacturing processes and improves the correlation between the lab and commercial manufacturing.
Company Growth (employees)
Emeryville, US
Size (employees)
363 (est)+5%
Zymergen was founded in 2013 and is headquartered in Emeryville, US

Key People/Management at Zymergen

Judy Gilbert

Judy Gilbert

Chief People Officer

Zymergen Office Locations

Zymergen has offices in Emeryville and Seattle
Emeryville, US (HQ)
5980 Horton St, Suite105
Seattle, US
2200 Alaskan Way

Zymergen Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$174.1 m

Latest funding size

$130 m

Time since last funding

about 1 year


Zymergen's latest funding round in October 2016 was reported to be $130 m. In total, Zymergen has raised $174.1 m

Zymergen's Web-traffic and Trends

Zymergen Online and Social Media Presence

Zymergen Company Life and Culture

You may also be interested in